nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

01.12.2013 | Original Article

Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease

verfasst von: Shivani Vats, Kawaljit K. Matharoo, Ajinder P. Singh, A. J. S. Bhanwer, Vasudha Sambyal

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Defect in insulin receptors or insulin signaling pathway is a hallmark of T2DM as it directly affects the endothelium. Coronary artery disease (CAD) being a comorbidity of T2DM, polymorphisms in genes of the insulin signaling pathway may affect an individual’s susceptibility to CAD. The objective of present study was to assess the association of CAD with polymorphisms in three genes of insulin signalling pathway; IRS1(G972R), IRS2 (G1057D) and PPARγ (Pro12Ala, C1431T). Blood samples were collected from 416 subjects of Punjabi origin; 200 CAD patients and 216 normal healthy controls matched for age and sex. For G972R polymorphism, Arg972 (A) allele carriers (GA+AA) had increased risk of CAD (OR: 1.92, CI: 1.13–3.29, P = 0.01) in overall population and in individuals with low BMI, HDL-C, high WHR, waist circumference, normal range of cholesterol and triglycerides. D allele of G1057D polymorphism was associated with increased risk of CAD (OR: 1.44, CI-1.08–1.92, P = 0.01) in overall population as well as in individuals with high BMI, WC, WHR and normal range of triglycerides and cholesterol. For PPARγ variants (Pro12Ala,C1431T), no statistical significant association was observed in the allelic and genotypic frequencies of cases and controls but TT genotype (C1431T) and G allele ( Pro12Ala) conferred protection against CAD in individuals with high cholesterol and normal HDL-C respectively. Statistically significant difference in the different genotypic combinations of IRS1 (G972R) with IRS2 (G1057D) and PPARγ (C1431T) confirmed their role in susceptibility to CAD in Punjabi population from North-west India.

Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis. 2000;149:251–66.PubMedCrossRef

Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidiol. 1996;7:217–26.CrossRef

Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, et al. Structure of insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 1991;352:73–7.PubMedCrossRef

Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG, Glasheen E, et al. Role of IRS-2 in insulin and cytokine signalling. Nature. 1995;377:173–7.PubMedCrossRef

Kobayashi T, Matsumoto T, Kamata K. The PI3-K pathway: roles related to alterations in vasomotor responses in diabetic models. J Smooth Mus Res. 2005;41:283–302.CrossRef

Bodhini D, Radha V, Deepa R, Ghosh S, Majumdar PP, Rao MR, et al. The G1057D polymorphism of IRS2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians. Int J Obes. 2007;31:97–102.CrossRef

Sanghera DK, Demirci FY, Been L, Ortega L, Ralhan S, Wander GS, et al. PPARG and ADIPOQ gene polymorphisms increase type2diabetes mellitus risk in Asian Indian Sikhs: pro12ala still remains a strongest predictor. Metabolism. 2010;59:492–501.PubMedCentralPubMedCrossRef

Bodhini D, Radha V, Mohan V. Association study of IRS1 gene polymorphisms with type 2 diabetes in South Indians. Diabetes Technol Ther. 2011;13:767–72.PubMedCrossRef

Baroni MG, D’ Andrea MP, Montali A, Kahn CR, Pannitteri G, Barilla F, et al. A common mutation in insulin receptor substrate 1 gene is a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol. 1999;19:2975–80.PubMedCrossRef

10.

Stohmer B, Holzl B, Paulweber B, Reiter R. The G972R polymorphism in the insulin receptor substrate (IRS-1) gene does not correlate with angiographic presence of significant coronary artery disease. J Clin Basic Cardiol. 2005;8:61–4.

11.

Ridker PM, Cook NR, Cheng, Erlich HA, Lindpaintner K, Pluztky J, et al. Alanine for proline subsitution in the peroxisome proliferator activated receptor gamma −2 ( PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol. 2003;23:859–63.PubMedCrossRef

12.

Vogel U, Segel S, Dethlefsen C, Tjonneland A, Saber AT, Wallin H, et al. PPAR gamma Pro12ala polymorphism and risk of acute coronary syndrome in prospective study of Danes. BMC Med Genet. 2009;10:52. doi:10.1186/1471-2350-10-52.PubMedCentralPubMedCrossRef

13.

Chan SH, Chen JH, Li YH, Tsai LM. Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population. J Biomed Sci. 2012;19:100. doi:10.1186/1423-0127-19-100.PubMedCrossRef

14.

Almind K, Inoue G, Pederson O, Kahn CR. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. J Clin Invest. 1996;97:2569–79.PubMedCentralPubMedCrossRef

15.

Fritsche A, Madaus A, Renn W, Tschritter O, Teigeler A, Weisser M, et al. The prevalent Gly1057Asp polymorphism in the insulin receptor substrate-2 gene is not associated with impaired insulin secretion. J Clin Endocrinol Metab. 2001;86:4822–5.PubMed

16.

Wang H, Rissanen J, Miettinen R, Karkkainen P, Kekalainen P, Kuusisto J, et al. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late onset type 2 diabetes. Diabetes. 2001;50:1949–51.PubMedCrossRef

17.

Rosen ED, Speigelman BM. PPARγ: a nuclear regulator of metabolism, differentiation and cell growth. J Biol Chem. 2001;276:37731–4.PubMedCrossRef

18.

Stumvoll M, Goldstein BJ, Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333–46.PubMedCrossRef

19.

Kumar M, Subhashini NGV, Kanthimathi S, Saibabu R, Ramesh A, Cherian KM, et al. Associations for lipoprotein lipase and peroxisome proliferatoractivated receptor-γ gene and coronary artery disease in an Indian population. Arch Med Res. 2010;41:19–25.CrossRef

20.

Galgani A, Valdes A, Erlich HA, Mano C, Cheng S, Petrone A, et al. Homozygosity for the Ala allele of the PPARγ2 Pro12Ala polymorphism is associated with reduced risk of coronary artery disease. Dis Markers. 2010;29:259–64.PubMedCrossRef

21.

Doney AS, Fischer B, Leese G, Morris AD, Palmer CN. Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go DARTS study. Arterioscler Thromb Vasc Biol. 2004;24:2403–7.PubMedCrossRef

22.

Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D, et al. Peroxisome proliferator activated receptor –γ2 P12A polymorphism and the risk of coronary heart disease in US men and women. Arterioscler Thromb Vasc Biol. 2005;25:1654–8.PubMedCrossRef

23.

Zhou A, Chen J, Xu W. Association between C1431T polymorphism in peroxisome proliferator-activated receptor-γ gene and coronary artery disease in Chinese Han population. Mol Bio Rep. 2012;39:1863–8.CrossRef

24.

Mohan V, Sandeep S, Deepa R, Shah B, Vargjese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007;125:217–30.PubMed

25.

Haseeb A, Iliyas M, Chakrabarti S, Farooqui AA, Naik SR, Ghosh S, et al. Single nucleotide polymorphisms in peroxisome proliferator activated receptor γ and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. J Biosci. 2009;34:405–14.PubMedCrossRef

26.

Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, et al. Impact of nine common type 2 diabetes risk polymorphism in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confers a significant risk. BMC Med Genet. 2008;9:59. doi:10.1186/1471-2350-9-59.PubMedCentralPubMedCrossRef

27.

Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, et al. Impact of Common Variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the Risk of Type 2 Diabetes in 5,164 Indians. Diabetes. 2010;59:2068–74.PubMedCrossRef

28.

Bhasin MK, Walter H, Danker Hopfeh. The distribution of Genetical, Morphological and Behavioural traits among the people of Indian origin. Kamla –Raj Publishers New Delhi; 1992.

29.

Kaur H, Sidhu S, Sambyal V. Association of obesity indices with type 2 diabetes mellitus and coronary artery disease. J Hum Ecol. 2010;29:185–90.

30.

Bhatti JS, Bhatti GK, Joshi A, Rai S, Mastana SS, Ralhan SK, et al. dentification of the risk factors for the high prevalence of type 2 diabetes and its complications in a Punjabi population:North Indian Diabetes study:A casecontrol study. Int J DiabDev Ctries. 2007;27:108–15.CrossRef

31.

Weiner JS. Lourie. Practical Human Biology. London: Blackwell Scientific Publication; 1981.

32.

WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention stratergies. Lancet. 2004;363:157–63.CrossRef

33.

Snehalatha C, Vishwanathan V, Ramachandran A. Cut-off values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26:1380–4.PubMedCrossRef

34.

Friedewald WT, Levy RI, Fredrickson DS. Estimaton of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chem. 1972;18:499–502.

35.

NCEP (III). Executive Summary of the third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults(Adult treatment panel III). JAMA. 2001;285:2486–97.CrossRef

36.

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988;16:1215.PubMedCrossRef

37.

Al-Shali KZ, House AA, Hanley AJG, Khan HMR, Harris SB, Zinman B, et al. Genetic variation in PPARG encoding Peroxisome proliferator- activated receptor γ associated with carotid atherosclerosis. Stroke. 2004;35:2036–40.PubMedCrossRef

38.

Atug O, Tahan V, Eren F, Tiftikci A, Imeryuz N, Hamzaoglu HO, et al. Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor gamma (PPARγ) Gene in Inflammatory Bowel Disease. J Gastrointestin Liver Dis. 2008;17:433–7.PubMed

39.

Lepretere F, Vionnet N, Budhan S, Dina C, Powell KL, Genin E, et al. Genetic studies of polymorphisms in ten insulin dependent diabetes mellitus candidate genes in Tamil Indians from Pondicherry. Diabetes Metab. 1998;23:244–50.

40.

Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, et al. Genetic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans. Hum Mol Genet. 1998;7:435–40.PubMedCrossRef

41.

Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP. Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies. Diabetologia. 2003;46:990–5.PubMedCrossRef

42.

Ossei-Gerning N, Mansfield MW, Stickland MH, Grant PJ. Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography. Clin Lab Haematol. 1997;19:123–8.PubMedCrossRef

43.

Mammarella S, Romano F, Di Valerio A, Creati B, Esposito DL, Palmirotta R, et al. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet. 2000;9:2517–21.PubMedCrossRef

44.

Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPAR gamma Pro12ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genet. 2000;26:76–80.PubMedCrossRef

45.

Mori Y, Kim–Motoyama H, Kakatura K, Yasuda K, Kadowaki H, Beamer BA, et al. Effect of peroxisome proliferator activated receptor gamma 2 gene on adiposity, fat distribution and insulin sensitivity in japanese men. Biochem Biophysics Res Commu. 1998;25:195–8.CrossRef

46.

Radha V, Vimaleswaran KS, Babu HN, Abate N, Chandalia M, Satija P. Role of genetic polymorphism peroxisome proliferator-activated receptor –gamma 2 Pro12ala on ethnic susceptibility to diabetes in south –Asians and caucasian subjects:evidence of heterogeneity. Diabetes Care. 2006;29:1046–51.PubMedCrossRef

47.

Bluher M, Klemm T, Gerike T, Krankenberg H, Schuler G, Paschke R. Lack of association between peroxisome proliferator-activated receptor-g-2 gene variants and the occurrence of coronary heart disease in patients with diabetes mellitus. Eur J Endocrinol. 2002;146:545–51.PubMedCrossRef

48.

Wan J, Xiongm S, Chao S, Xiao J, Ma Y, Wang J, et al. PPARγ gene C161T subsitution alters lipid profile in chinese patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol. 2010;24:9–13.

49.

Tai ES, Corella D, Deurenberg- Yap M, Adiconis X, et al. Differential effects of the C1431T and Pro12 ala PPARγ gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res. 2004;45:674–85.PubMedCrossRef

Titel: Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease
verfasst von: Shivani Vats
Kawaljit K. Matharoo
Ajinder P. Singh
A. J. S. Bhanwer
Vasudha Sambyal
Publikationsdatum: 01.12.2013
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 4/2013
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-013-0150-2

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Type 2 diabetes mellitus (T2DM) subjects of Bangladeshi origin with fast N-acetyltransferase 2 (NAT2) acetylator phenotype show lower insulin sensitivity than slow acetylator phenotype

Permanent neonatal diabetes due to a novel L105P (c.314T>C; p.Leu105Pro) heterozygous mutation in insulin gene

Calreticulin novel mutations in type 2 diabetes mellitus

mtDNA 16184–16193 poly-C tract does not predispose to type 2 diabetes in the Mauritanian population

Variations in association of Interleukin 6 -G174C single nucleotide polymorphism with type 2 diabetes mellitus—a review

Polymorphisms in Mn-SOD and EC-SOD gene and risk of nephropathy in Western Indian Type 2 diabetic patients